More on PYPD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $3.90 |
|
|||
| Open | $3.95 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $4.11 | ||||
| Day Low | $3.90 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 69,747 | ||||
- H.C. Wainwright Reiterates Buy Rating on PolyPid Ltd. (PYPD)
- Form 6-K PolyPid Ltd. For: Jul 21
- PolyPid partners with Azurity for D-PLEX100 U.S. and Canada rights
- PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
- PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
- Form 4 PolyPid Ltd. For: May 11 Filed by: Warshavsky Ori
- Form 4 PolyPid Ltd. For: May 11 Filed by: Missulawin Jonathan
- Form 4 PolyPid Ltd. For: May 11 Filed by: Hazan Dalit Fellous
- Form 4 PolyPid Ltd. For: Jul 15 Filed by: Barenholz Yechezkel
- Form 4 PolyPid Ltd. For: Jul 15 Filed by: Stein Robert Benjamin
Entities mentioned with PYPD
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- IPO | View Related Stories »
- Show More...
